Active substanceOxyethylammonium methylphenoxyacetateOxyethylammonium methylphenoxyacetate
Similar drugsTo uncover
  • Trekresan
    pills inwards 
    PHARMATRIX LLC     Russia
  • Dosage form: & nbsppills
    Composition:

    1 tablet contains:

    Active substance:

    Oxyethylammonium methylphenoxyacetate 0.2 g

    (cracked)

    Excipients:

    Potato starch 0,095 g

    Milk sugar (lactose monohydrate) 0.2 g

    Calcium stearate (calcium stearate) 0,005 in

    Description:

    Tablets white or white with a yellowish or kremovatym color shade, flat-cylindrical.

    Pharmacotherapeutic group:Adaptogenic agent
    ATX: & nbsp

    A.13.A   Tetanus preparations

    Pharmacodynamics:

    Trekrezan belongs to the group of adaptogenic preparations. Trekrizan stimulates the production of alpha and gamma interferons, which determines the spectrum of its biological activity (immunostimulating, adaptogenic), affects the immune status of the organism by activating the cellular and humoral units of immunity, stimulates the phagocytic activity of macrophages. The exact mechanism of action of oxyethylammonium methylphenoxyacetate is not established.

    These immunological effects of the drug, promote endurance in physical and mental loads, reduce the effect of various toxins, increase the body's resistance to hypoxia,low and high temperatures and other adverse environmental factors.
    Pharmacokinetics:

    According to available data oxyethylammonium methylphenoxyacetate has high bioavailability, is rapidly metabolized in the liver, excreted by the kidneys mainly in the form of glucuronides. Do not cumulate in the body with prolonged use.

    Pharmacokinetics in special clinical cases

    In elderly people, children 12-18 years old, patients with renal and hepatic insufficiency, the pharmacokinetics of oxyethylammonium methylphenoxyacetate does not change significantly.

    Indications:

    As part of complex therapy:

    - in the prevention and treatment of acute respiratory viral infections;

    - in the period of high intellectual and heavy physical exertion;

    - To increase the resistance of the organism to various stress effects (hypoxia, overheating, hypothermia) and adverse environmental effects (sudden changes in climatic conditions, adaptation to atmospheric pressure drops).

    Contraindications:

    Hypersensitivity to any of the components of the drug.

    Children under 12 years of age (due to the lack of data on the effectiveness and safety of application).

    Hereditary lactose intolerance, lactase deficiency or disorder absorption of glucose and galactose.

    Carefully:

    Diabetes mellitus (see section "Special instructions").

    Pregnancy and lactation:

    Contraindicated in pregnancy and during breastfeeding (in the lack of data on effectiveness and safety of use).

    Dosing and Administration:Inside.

    - for the prevention of acute respiratory viral infections in the complex therapy: adults and children over 12 years are prescribed - 1 tablet (200 mg) per day after meals. In total, there are 14 tablets (total dose of 2800 mg) per course, the course duration is 14 days;

    - for the treatment of acute respiratory viral infections as part of complex therapy: adults and children over 12 years of age are prescribed - on the first day 1 tablet 3 times (600 mg) per day, in the next 7 days 1 tablet (200 mg). In total for the course of 10 tablets (total dose of 2000 m.), The duration of the course is 8 days.

    - in the period of high intellectual and heavy physical exertion as part of complex therapy, adults and children over 12 years of age are prescribed - on the first day 3 tablets (600 mg) per day, for the next 7 days, 1 tablet (200 mg).In total, the course of 10 tablets (total dose of 2000 mg), the duration of the course is 8 days.

    - to increase the resistance of the organism to various stress effects (hypoxia, overheating, hypothermia) and adverse environmental effects (sudden changes in climatic conditions, adaptation to atmospheric pressure changes), in the complex therapy for adults and children over 12 years of age - on the first day 3 tablets 600 mg) per day, for the next 7 days, 1 tablet (200 mg). In total, the course of 10 tablets (total dose of 2000 mg), the duration of the course is 8 days.

    If after 3 days of treatment there is no improvement in well-being and the symptoms of the above conditions do not decrease or become more pronounced, the patient should consult a doctor.

    Side effects:In rare cases, allergic reactions are possible: hypersensitivity reactions, anaphylactic shock, anaphylaxis, and Quincke's edema.

    If any of the unwanted reactions listed in the manual is aggravated, or if you notice any other undesirable reactions not listed in the instructions, tell your doctor.

    Overdose:Symptoms of intoxication due to an overdose of the drug are not noted.In case of overdose, symptomatic therapy is recommended.

    Interaction:Undesirable interaction with other medicinal products is not described.

    Special instructions:

    Patients with diabetes should be careful when using Trecresan.

    In the case of acute respiratory viral infection, if you have the following signs, they usually indicate a more serious condition and require mandatory treatment to a specialist - a family doctor or therapist: 1) increased body temperature above 39 ° C (high fever ); 2) fever is accompanied by severe pain, shortness of breath, impaired consciousness, convulsions; 3) with symptoms of acute respiratory disease, body temperature above 38.5 ° C is observed for 3 days or more; 4) the temperature above 37.5 ° C lasts 2 weeks or more.

    Given that the pharmacokinetic parameters of oxyethylammonium methylphenoxyacetate do not change significantly, there is no need to observe any specific features and limitations of the drug in children 12-18 years old, elderly patients, patients with impaired liver function, kidneys, other than those specified in the instructions.

    Do not exceed the recommended dosage.

    Effect on the ability to drive transp. cf. and fur:The use of the drug does not affect the management of motor vehicles and occupations of potentially hazardous activities requiring increased concentration of attention and speed of psychomotor reactions.
    Form release / dosage:Tablets 200 mg.

    Packaging:

    10 tablets are placed in a contour mesh box made of a polyvinylchloride film and foil of an aluminum printed lacquered or, instead of a foil, packaging paper with a polymer coating.

    For 1, 2 or 5 contour squares, together with the instructions for use, are placed in a pack of cardboard.

    Storage conditions:

    Store in a dry place protected from light.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-008909/09
    Date of registration:06.11.2009 / 25.03.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:PHARMATRIX LLCPHARMATRIX LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp23.03.2017
    Illustrated instructions
      Instructions
      Up